$PHAR· SEC filing ·

PHAR Reports $1.2B Revenue, $0.05 EPS, +18% YoY Growth, Launches New Product Line

Pharming Group N.V. ADS, each representing 10 ordinary shares · Now $13.10

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS